Murdo Ferguson

2.4k total citations
15 papers, 318 citations indexed

About

Murdo Ferguson is a scholar working on Epidemiology, Microbiology and Immunology. According to data from OpenAlex, Murdo Ferguson has authored 15 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 5 papers in Microbiology and 4 papers in Immunology. Recurrent topics in Murdo Ferguson's work include Influenza Virus Research Studies (9 papers), Respiratory viral infections research (5 papers) and Pneumonia and Respiratory Infections (5 papers). Murdo Ferguson is often cited by papers focused on Influenza Virus Research Studies (9 papers), Respiratory viral infections research (5 papers) and Pneumonia and Respiratory Infections (5 papers). Murdo Ferguson collaborates with scholars based in Belgium, United States and Canada. Murdo Ferguson's co-authors include Marc Dionne, Tino F. Schwarz, Brian Ramjattan, Karin Schulze, Ulrich Behre, Frank Struyf, Klaus Peters, Linda M. Ferguson, Barbara Romanowski and Peter Hillemanns and has published in prestigious journals such as The Journal of Infectious Diseases, Vaccine and Respiratory Research.

In The Last Decade

Murdo Ferguson

15 papers receiving 314 citations

Peers

Countries citing papers authored by Murdo Ferguson

Since Specialization

Citations

This map shows the geographic impact of Murdo Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murdo Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murdo Ferguson more than expected).

Fields of papers citing papers by Murdo Ferguson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murdo Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murdo Ferguson. The network helps show where Murdo Ferguson may publish in the future.

Co-authorship network of co-authors of Murdo Ferguson

This figure shows the co-authorship network connecting the top 25 collaborators of Murdo Ferguson. A scholar is included among the top collaborators of Murdo Ferguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murdo Ferguson. Murdo Ferguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion Maternal Vaccine Coadministered With Diphtheria-Tetanus-Pertussis Vaccine: A Phase 2 Study 2023 ·The Journal of Infectious Diseases ·(unknown), Murdo Ferguson, Isabel Leroux‐Roels, (unknown), (unknown), Nancy Hua, Peter van Steen, (unknown), Ilse Dieussaert, Joon Hyung Kim	10
2	Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study 2022 ·Respiratory Research ·(unknown), (unknown), Daniela Casula, (unknown), Michel Janssens, Annaelisa Tasciotti, Tino F. Schwarz, Murdo Ferguson, Ashwani Kumar Arora	4
3	Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine 2019 ·Vaccine ·Terry Nolan, Marı́a Elena Santolaya, Ferdinandus de Looze, Helen Marshall, Peter Richmond, Sam Henein, (unknown), (unknown), Kirsten P. Perrett, Hartley Garfield, Anil Kumar Gupta, Murdo Ferguson, Diego D’Agostino, Daniela Toneatto, Miguel O’Ryan	38
4	Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine 2019 ·The Journal of Infectious Diseases ·Nicolas Folschweiller, Ulrich Behre, Marc Dionne, Paolo Durando, Susanna Esposito, Linda Ferguson, Murdo Ferguson, Peter Hillemanns, Shelly McNeil, Klaus Peters, Brian Ramjattan, Tino F. Schwarz, Khuanchai Supparatpinyo, (unknown), Michel Janssens, Philippe Moris, Annabelle Decreux, Sylviane Poncelet, Frank Struyf	12
5	152. Protective Antibody Levels 7.5 Years After Primary Vaccination in Adolescence With a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine (4CMenB) and Response to a Booster Dose in Adolescents and Young Adults: Phase IIIb Clinical Findings 2018 ·Open Forum Infectious Diseases ·Terry Nolan, Miguel O’Ryan, Marı́a Elena Santolaya, Ferdinandus de Looze, Helen Marshall, Peter Richmond, Sam Henein, (unknown), (unknown), Kirsten P. Perrett, Hartley Garfield, Anil Kumar Gupta, Murdo Ferguson, Diego D’Agostino, Daniela Toneatto	1
6	Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial 2018 ·Vaccine ·Céline Maréchal, Himal Lal, Airi Põder, Murdo Ferguson, (unknown), Thomas C. Heineman, Caroline Hervé, (unknown), (unknown), (unknown), Lidia Oostvogels	27
7	Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65 years of age and older: A phase II, observer-blind, randomized, controlled trial 2017 ·Vaccine ·(unknown), Murdo Ferguson, (unknown), David Seiden, (unknown), Damien Friel, Jyoti Soni, Ping Li, Bruce L. Innis, Anne Schuind	12
8	Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial 2017 ·Vaccine ·(unknown), Murdo Ferguson, Eric Sheldon, Nathan Segall, Laurence Chu, (unknown), (unknown), Damien Friel, Jyoti Soni, Ping Li, Bruce L. Innis, Anne Schuind	10
9	Persistence of Bactericidal Activity at 4 Years After 2 Primary Doses of a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine (4CMenB) and Response to a Booster Dose in Adolescents and Young Adults 2017 ·Open Forum Infectious Diseases ·Terry Nolan, Hartley Garfield, Anil Kumar Gupta, Murdo Ferguson, Helen Marshall, Diego D’Agostino, Daniela Toneatto	3
10	Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults 2016 ·The Journal of Infectious Diseases ·(unknown), Nathan Segall, Murdo Ferguson, Louise Frenette, Robin Kroll, Damien Friel, Jyoti Soni, Ping Li, Bruce L. Innis, Anne Schuind	37
11	Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus 2016 ·Human Vaccines & Immunotherapeutics ·Olivier Van Der Meeren, James T. Peterson, Marc Dionne, Richard Beasley, Peter R. Ebeling, Murdo Ferguson, Michael D. Nissen, (unknown), Richard W Simpson, (unknown), Priya Diana Crasta, Jacqueline M. Miller, Andrew F. Trofa	24
12	Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib vaccine in Canadian Aboriginal and non-Aboriginal infants 2015 ·Vaccine ·David W. Scheifele, Murdo Ferguson, Gerald Predy, Meena Dawar, Deepak Assudani, Sherine Kuriyakose, Olivier Van Der Meeren, (unknown)	7
13	Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination 2014 ·Human Vaccines & Immunotherapeutics ·Barbara Romanowski, Tino F. Schwarz, Linda M. Ferguson, Murdo Ferguson, Klaus Peters, Marc Dionne, Karin Schulze, Brian Ramjattan, Peter Hillemanns, Ulrich Behre, P.V. Suryakiran, Florence Thomas, Frank Struyf	85
14	1087Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants 2014 ·Open Forum Infectious Diseases ·David W. Scheifele, Murdo Ferguson, Gerald Predy, Meena Dawar, Deepak Assudani, Sherine Kuriyakose, Olivier Van Der Meeren, Htay Htay Han	1
15	Safety and Long-term Humoral Immune Response in Adults After Vaccination With an H1N1 2009 Pandemic Influenza Vaccine With or Without AS03 Adjuvant 2012 ·The Journal of Infectious Diseases ·Murdo Ferguson, George Risi, Matthew Davis, Eric Sheldon, Mira Baron, Ping Li, Miguel G. Madariaga, Louis Fries, Olivier Godeaux, David W. Vaughn	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact